Mkts

Nephros, Inc.

NASDAQ: NEPH
$3.25+0.01 (+0.31%)
As of Nov 4, 4:00 PM ET

Key statistics

Day range
3.203.30
52-week range
2.666.42
Today
Open3.28
Previous close3.25
Volume35.8K
Valuation
Market cap34.89M
P/E ratio20.10×
EPS (TTM)0.16
Income & risk
Dividend / yield—
Beta1.82
Avg volume30.5K
Discussion

NEPH News

Stories mentioning NEPH from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue5,2124,7294,7644,4194,8773,8703,5183,252
Cost of Goods Sold2,2191,9681,8491,6241,7231,3951,3691,340
Gross Profit2,9932,7612,9152,7953,1542,4752,1491,912
Operating Expenses
Research & Development346.00395.00338.00311.00295.00252.00188.00254.00
Sales General & Admin2,5212,3162,2292,2012,2541,8721,7211,941
Total Operating Expenses2,8962,7432,6012,5472,5882,1581,9432,229
Operating Income (Loss)97.0018.00314.00248.00566.00317.00206.00(317.00)
Interest Income
Interest Expense
Other Expense11.00(10.00)(15.00)(32.00)(21.00)19.00(43.00)7.00
Pretax Income340.00246.00183.00(289.00)
Tax Provision0.000.003.009.000.0015.000.000.00
Net Income (Loss)140.0062.00337.00237.00558.00349.00183.00(289.00)
Earnings Per Share (Basic)0.010.010.030.020.050.030.02(0.03)
Earnings Per Share (Diluted)0.010.010.030.020.050.030.02(0.03)
Weighted Average Shares Outstanding (Basic)10,65110,61210,61210,60010,60010,52510,54410,510
Weighted Average Shares Outstanding (Diluted)10,99110,96811,04110,81310,61610,60210,58110,510

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NEPH

Nephros, Inc. (NASDAQ: NEPH) is a stock listed on the Nasdaq Stock Market under the ticker symbol NEPH. It last traded at $3.25 (Nov 4, 2026, 4:00 PM ET), up 0.3% on the day. That gives Nephros a market capitalisation of $34.9M and a price-to-earnings ratio of 20.1.

Over the past 52 weeks NEPH has traded between $2.66 and $6.42.

Revenue for the quarter ended Mar 31, 2026 was $5.2M; net income $140.0K. Revenue was up 6.9% from $4.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$5.2M$140.0K2.7%
Dec 31, 2025$4.7M$62.0K1.3%
Sep 30, 2025$4.8M$337.0K7.1%
Jun 30, 2025$4.4M$237.0K5.4%

From Nephros’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…